When to reinvite initially ineligible populations for targeted lung cancer screening?
Introduction Targeted low-dose CT lung cancer screening reduces lung cancer mortality. England’s Targeted Lung Health Check programme uses risk prediction tools to determine eligibility for biennial screening among people with a smoking history aged 55–74. Some participants initially ineligible for...
| Published in: | BMJ Open Respiratory Research |
|---|---|
| Main Authors: | Matthew Sperrin, Haval Balata, Richard Booton, Philip A J Crosbie, Zoe Merchant, Patrick Goodley |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-06-01
|
| Online Access: | https://bmjopenrespres.bmj.com/content/11/1/e002193.full |
Similar Items
Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort
by: Matthew Sperrin, et al.
Published: (2024-07-01)
by: Matthew Sperrin, et al.
Published: (2024-07-01)
The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening
by: Haval Balata, et al.
Published: (2023-05-01)
by: Haval Balata, et al.
Published: (2023-05-01)
The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screeningCentral MessagePerspective
by: Nanruoyi Zhou, MD, et al.
Published: (2023-03-01)
by: Nanruoyi Zhou, MD, et al.
Published: (2023-03-01)
Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma
by: Matthew J. Pianko, et al.
Published: (2025-12-01)
by: Matthew J. Pianko, et al.
Published: (2025-12-01)
Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards
by: Matthew Evison, et al.
Published: (2021-01-01)
by: Matthew Evison, et al.
Published: (2021-01-01)
Differences in seeking breast cancer care between screening eligible versus ineligible Palestinian women
by: Mohamedraed Elshami, et al.
Published: (2025-07-01)
by: Mohamedraed Elshami, et al.
Published: (2025-07-01)
Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases
by: Márcia M Ferreira-Silva, et al.
Published: (2010-09-01)
by: Márcia M Ferreira-Silva, et al.
Published: (2010-09-01)
Removal of ineligible outcome cases reduces confounding
by: Walker AM, et al.
Published: (2018-05-01)
by: Walker AM, et al.
Published: (2018-05-01)
Endobronchial lymphoma – A rare cause of airway obstruction
by: Kavita Sivabalah, et al.
Published: (2023-01-01)
by: Kavita Sivabalah, et al.
Published: (2023-01-01)
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD
by: Claire Bradley, et al.
Published: (2023-08-01)
by: Claire Bradley, et al.
Published: (2023-08-01)
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk
by: Richard D Neal, et al.
Published: (2020-09-01)
by: Richard D Neal, et al.
Published: (2020-09-01)
Chronic Pulmonary Aspergillosis after Surgical Treatment for Non-Small Cell Lung Cancer—An Analysis of Risk Factors and Clinical Outcomes
by: George Whittaker, et al.
Published: (2024-05-01)
by: George Whittaker, et al.
Published: (2024-05-01)
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
by: Carmelo Gurnari, et al.
Published: (2022-12-01)
by: Carmelo Gurnari, et al.
Published: (2022-12-01)
Percutaneous Radiofrequency Ablation of Thyroid Carcinomas Ineligible for Surgery, in the Elderly
by: Pierre Yves Marcy, et al.
Published: (2023-08-01)
by: Pierre Yves Marcy, et al.
Published: (2023-08-01)
Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?
by: Mohammad Jad Moussa, et al.
Published: (2024-02-01)
by: Mohammad Jad Moussa, et al.
Published: (2024-02-01)
LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China
by: Ting Bao, et al.
Published: (2024-02-01)
by: Ting Bao, et al.
Published: (2024-02-01)
Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy
by: Qiuji Wu, et al.
Published: (2025-05-01)
by: Qiuji Wu, et al.
Published: (2025-05-01)
Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
by: Rachel Broadbent, et al.
Published: (2023-11-01)
by: Rachel Broadbent, et al.
Published: (2023-11-01)
Exclusion of enrolled participants in randomised controlled trials: what to do with ineligible participants?
by: Elizabeth Allen, et al.
Published: (2020-12-01)
by: Elizabeth Allen, et al.
Published: (2020-12-01)
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens
by: Li LF, et al.
Published: (2024-04-01)
by: Li LF, et al.
Published: (2024-04-01)
P067: A pilot of lung cancer screening for survivors of Hodgkin lymphoma
by: Rachel Broadbent, et al.
Published: (2022-10-01)
by: Rachel Broadbent, et al.
Published: (2022-10-01)
Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma
by: Takafumi Fukushima, et al.
Published: (2025-07-01)
by: Takafumi Fukushima, et al.
Published: (2025-07-01)
Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
by: Leiming Xia, et al.
Published: (2023-05-01)
by: Leiming Xia, et al.
Published: (2023-05-01)
Clinical prediction in defined populations: a simulation study investigating when and how to aggregate existing models
by: Glen P. Martin, et al.
Published: (2017-01-01)
by: Glen P. Martin, et al.
Published: (2017-01-01)
THERAPY FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WHO PRESENT LATE OR ARE INELIGIBLE FOR REPERFUSION
by: M. Cohen, et al.
Published: (2016-01-01)
by: M. Cohen, et al.
Published: (2016-01-01)
Elective semaglutide prescription enabled waitlisting and transplantation of otherwise ineligible obese renal transplant candidates
by: Emilie Navaux, et al.
Published: (2025-10-01)
by: Emilie Navaux, et al.
Published: (2025-10-01)
Durvalumab Combined With Pemetrexed-Based Chemotherapy in Trial-Ineligible Patients With Mesothelioma: A Brief Report
by: Ibiayi Dagogo-Jack, MD, et al.
Published: (2025-05-01)
by: Ibiayi Dagogo-Jack, MD, et al.
Published: (2025-05-01)
Balloon pulmonary angioplasty for proximal chronic thromboembolic pulmonary hypertension in patients ineligible for pulmonary endarterectomy
by: Justin Issard, et al.
Published: (2024-07-01)
by: Justin Issard, et al.
Published: (2024-07-01)
Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions
by: Paul Sackstein, et al.
Published: (2024-04-01)
by: Paul Sackstein, et al.
Published: (2024-04-01)
Yorkshire Lung Screening Trial (YLST) pathway navigation study: a protocol for a nested randomised controlled trial to evaluate the effect of a pathway navigation intervention on lung cancer screening uptake
by: Matthew E J Callister, et al.
Published: (2024-07-01)
by: Matthew E J Callister, et al.
Published: (2024-07-01)
Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial
by: Martyn P T Kennedy, et al.
Published: (2023-07-01)
by: Martyn P T Kennedy, et al.
Published: (2023-07-01)
Influences on Lung Cancer Screening Initiation and Retention in Rural Alabama
by: Amy Copeland, et al.
Published: (2023-04-01)
by: Amy Copeland, et al.
Published: (2023-04-01)
Colorectal Cancer Screening—Who, How, and When?
by: Roisin Bevan, et al.
Published: (2018-01-01)
by: Roisin Bevan, et al.
Published: (2018-01-01)
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
by: Katja Gutmair, et al.
Published: (2025-05-01)
by: Katja Gutmair, et al.
Published: (2025-05-01)
Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma
by: Yan Wang, et al.
Published: (2025-02-01)
by: Yan Wang, et al.
Published: (2025-02-01)
Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria
by: Taiwo Ibinaiye, et al.
Published: (2024-03-01)
by: Taiwo Ibinaiye, et al.
Published: (2024-03-01)
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
by: Francesca Bonello, et al.
Published: (2020-12-01)
by: Francesca Bonello, et al.
Published: (2020-12-01)
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
by: Diana Al-Sarayfi, et al.
Published: (2022-09-01)
by: Diana Al-Sarayfi, et al.
Published: (2022-09-01)
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
by: Noemi Puig, et al.
Published: (2021-05-01)
by: Noemi Puig, et al.
Published: (2021-05-01)
Correcting for case-mix shift when developing clinical prediction models
by: Haya Elayan, et al.
Published: (2025-08-01)
by: Haya Elayan, et al.
Published: (2025-08-01)
Similar Items
-
Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort
by: Matthew Sperrin, et al.
Published: (2024-07-01) -
The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening
by: Haval Balata, et al.
Published: (2023-05-01) -
The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screeningCentral MessagePerspective
by: Nanruoyi Zhou, MD, et al.
Published: (2023-03-01) -
Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma
by: Matthew J. Pianko, et al.
Published: (2025-12-01) -
Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards
by: Matthew Evison, et al.
Published: (2021-01-01)
